Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Analysis of On-Target and Off-Target Resistance Factors Associated with Gilteritinib Efficacy in Relapsed or Refractory AML Patients with FLT3 Mutations

Blood (2024) 144 (Supplement 1): 6090.

https://doi.org/10.1182/blood-2024-199957

Published: 2024

Journal Articles

Prospective Evaluation of Allogeneic HSCT at the First Remission for Younger Adults with FLT3 -ITD Positive Acute Myeloid Leukemia: The JALSG AML209-FLT3-SCT Study

Blood (2019) 134 (Supplement_1): 1328.

https://doi.org/10.1182/blood-2019-124394

Published: 2019

Journal Articles

RhoH Downregulates Rac Through RhoGAP Family Protein

Akira Katsumi, MD, PhD, Miki Kobayashi, MD, PhD, Tadashi Matsushita, MD, PhD, Hitoshi Kiyoi, MD, PhD, Tetsuhito Kojima, MD, PhD, Mitsuo Maruyama, PhD, Kozo Kaibuchi, MD, PhD, Tomoki Naoe, MD, PhD

Blood (2011) 118 (21): 4792.

https://doi.org/10.1182/blood.V118.21.4792.4792

Published: 2011

Journal Articles

Prognostic Implications and Biological Roles of RhoH in Acute Myeloid Leukemia.

Toshihiro Iwasaki, MD, Akira Katsumi, M.D., Ph.D., Hitoshi Kiyoi, M.D., Ph.D., Ryohei Tanizaki, Miki Kobayashi, M.D., Ph.D., Akihiro Abe, M.D., Ph.D., Tadashi Matsushita, M.D., Ph.D., Tomoki Naoe, M.D., Ph.D.

Blood (2007) 110 (11): 4246.

https://doi.org/10.1182/blood.V110.11.4246.4246

Published: 2007

Journal Articles

Analysis of the Expression of an Endogenous Tumor Suppressor Gene, PHLPP, and Elevation of PHLPP as an Ideal Target for MRD Monitoring in Leukemia.

Takaaki Ono, MD, Satoki Nakamura, MD,PhD, Yuya Sugimoto, MD, Miki Kobayashi, MD,PhD, Naohi Sahara, MD,PhD, Kaori Shinjo, MD,PhD, Kazuyuki Shigeno, MD,PhD, Shinya Fujisawa, MD, Kazunori Ohnishi, MD,PhD

Blood (2006) 108 (11): 4327.

https://doi.org/10.1182/blood.V108.11.4327.4327

Published: 2006

Journal Articles

Bcr-Abl Inhibitors Induce Expression of HoxA10, Playing a Role as an Inhibitor of the Proliferation through PI3K/PKB Pathway in Chronic Myelogenous Leukemia Cells.

Yuya Sugimoto, MD, Satoki Nakamura, MD,PhD, Takaaki Ono, MD, Miki Kobayashi, MD,PhD, Naohi Sahara, MD,PhD, Kaori Shinjo, MD,PhD, Kazuyuki Shigeno, MD,PhD, Kazunori Ohnishi, MD,PhD

Blood (2006) 108 (11): 1363.

https://doi.org/10.1182/blood.V108.11.1363.1363

Published: 2006

Journal Articles

Analysis of Aurora Kinase Expressions and Cell Cycle Regulation by Aurora-C in Leukemia Cells.

Miki Kobayashi, MD, PhD, Satoki Nakamura, MD, PhD, Takaaki Ono, MD, Yuya Sugimoto, MD, Naohi Sahara, MD, PhD, Kaori Shinjo, MD, PhD, Kazuyuki Shigeno, MD, PhD, Kazunori Ohnishi, MD, PhD

Blood (2006) 108 (11): 1366.

https://doi.org/10.1182/blood.V108.11.1366.1366

Published: 2006

Journal Articles

Analysis of FoxM1 Expression and Regulation of Cell Cycle, and Anti-Leukemic Effectss by FoxM1 Knockdown on Leukemia Cells Transfected with siRNA FoxM1.

Satoki Nakamura, MD, PhD, Takaaki Ono, MD, Yuya Sugimoto, MD, Miki Kobayashi, MD,PhD, Naohi Sahara, MD,PhD, Kazuyuki Shigeno, MD,PhD, Kaori Shinjo, MD,PhD, Shinya Fujisawa, MD,PhD, Kazunori Ohnishi, MD,PhD

Blood (2006) 108 (11): 4320.

https://doi.org/10.1182/blood.V108.11.4320.4320

Published: 2006

Journal Articles

Etodolac Inhibits EBER Expression and Induces Bcl-2-Regulated Apoptosis in Burkitt’s Lymphoma Cells.

Miki Kobayashi, MD, Satoki Nakamura, MD, PhD, Kiyoshi Shibata, Naohi Sahara, MD, PhD, Kazuyuki Shigeno, MD, PhD, Kaori Shinjo, MD, PhD, Kensuke Naito, MD, PhD, Kazunori Ohnishi, MD, PhD

Blood (2005) 106 (11): 4825.

https://doi.org/10.1182/blood.V106.11.4825.4825

Published: 2005

Journal Articles

Elevation of Kinase Interacting with Stathmin (KIS) and Promotion of Cellcycle Progression by KIS in Leukemia Cells.

Satoki Nakamura, MD, PhD, Takaaki Ono, MD., Yuya Sugimoto, MD., Miki Kobayashi, MD., Naohi Sahara, MD.PhD, Kaori Shinjo, MD.PhD, Kazuyuki Shigeno, MD.PhD, Kazunori Ohnishi, MD.PhD

Blood (2005) 106 (11): 1365.

https://doi.org/10.1182/blood.V106.11.1365.1365

Published: 2005

Journal Articles

Pharmacokinetics of Arsenic Species with Relapsed or Refractory Acute Promyelocytic Leukemia (APL) Treated with Arsenic Trioxide (ATO) in Japanese Patients.

Kazuyuki Shigeno, MD, Miki Kobayashi, MD, Naohi Sahara, MD, Satoki Nakamura, MD, Shinya Fujisawa, MD, Kensuke Naito, MD, Kaori Shinjo, MD, Akihiro Takeshita, MD, Ryuzo Ohno, MD, Kenji Kinoshita, PhD, Masahito Shimoya, PhD, Toshikazu Kaise, PhD, Kazunori Ohnishi, MD

Blood (2005) 106 (11): 4426.

https://doi.org/10.1182/blood.V106.11.4426.4426

Published: 2005

Journal Articles

Etodolac Induces Apoptosis and Inhibits Cell Adhesion to Bone Marrow Stromal Cells in Human Myeloma Cells.

Satoki Nakamura, MD, PhD, Miki Kobayashi, MD, Kiyoshi Shibata, Naohi Sahara, MD, Kazuyuki Shigeno, MD, PhD, Kaori Shinjo, MD, PhD, Kensuke Naito, MD, PhD, Kazunori Ohnishi, MD, PhD

Blood (2004) 104 (11): 4836.

https://doi.org/10.1182/blood.V104.11.4836.4836

Published: 2004

Journal Articles

Role for Interleukin-6 and Insulin like Growth Factor-I Via PI3-K/Akt Pathway in the Proliferation of CD56-Negative and Positive Multiple Myeloma Cells.

Naohi Sahara, Akihiro Takeshita, Miki Kobayashi, Kazuyuki Shigeno, Satoki Nakamura, Kaori Shinjo, Kensuke Naito, Takemi Otsuki, Kazunori Ohnishi, Ryuzo Ohno

Blood (2004) 104 (11): 3365.

https://doi.org/10.1182/blood.V104.11.3365.3365

Published: 2004

NARROW

Analysis of On-Target and Off-Target Resistance Factors Associated with Gilteritinib Efficacy in Relapsed or Refractory AML Patients with FLT3 Mutations

Prospective Evaluation of Allogeneic HSCT at the First Remission for Younger Adults with FLT3 -ITD Positive Acute Myeloid Leukemia: The JALSG AML209-FLT3-SCT Study

RhoH Downregulates Rac Through RhoGAP Family Protein

Prognostic Implications and Biological Roles of RhoH in Acute Myeloid Leukemia.

Analysis of the Expression of an Endogenous Tumor Suppressor Gene, PHLPP, and Elevation of PHLPP as an Ideal Target for MRD Monitoring in Leukemia.

Bcr-Abl Inhibitors Induce Expression of HoxA10, Playing a Role as an Inhibitor of the Proliferation through PI3K/PKB Pathway in Chronic Myelogenous Leukemia Cells.

Analysis of Aurora Kinase Expressions and Cell Cycle Regulation by Aurora-C in Leukemia Cells.

Analysis of FoxM1 Expression and Regulation of Cell Cycle, and Anti-Leukemic Effectss by FoxM1 Knockdown on Leukemia Cells Transfected with siRNA FoxM1.

Etodolac Inhibits EBER Expression and Induces Bcl-2-Regulated Apoptosis in Burkitt’s Lymphoma Cells.

Elevation of Kinase Interacting with Stathmin (KIS) and Promotion of Cellcycle Progression by KIS in Leukemia Cells.

Pharmacokinetics of Arsenic Species with Relapsed or Refractory Acute Promyelocytic Leukemia (APL) Treated with Arsenic Trioxide (ATO) in Japanese Patients.

Etodolac Induces Apoptosis and Inhibits Cell Adhesion to Bone Marrow Stromal Cells in Human Myeloma Cells.

Role for Interleukin-6 and Insulin like Growth Factor-I Via PI3-K/Akt Pathway in the Proliferation of CD56-Negative and Positive Multiple Myeloma Cells.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only